Tuesday, October 16, 2018
 
 
Company News: Page (1) of 1 - 01/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Novartis new data reinforces superiority of Cosentyx® versus Stelara® in achieving skin clearance for psoriasis patients
-- Results from CLARITY study show Cosentyx® (secukinumab) was significantly more effective than Stelara® (ustekinumab) in delivering clear and almost clear skin at 12 weeks and at 16 weeks(1)-- Data ...
(January 16, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA,Medicine,Disease,healthcare,Therapy,Technology,Surgery,Medication,Vitamins/Nutrition,Womens Health,Physician,Nurse,Health Technologist,Science,Medical Technology,Medical,Adults,Other,Medical Professionals,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines